Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Dillards
DDS
$9.2B
| $1.93M | ﹤0.01% |
5,825
-4,754
| -45% | -$1.57M |
|
1952
Stantec
STN
$8.17B
| $1.92M | ﹤0.01% |
29,456
-11,739
| -28% | -$781K |
|
1953
Associated Banc-Corp
ASB
$5.8B
| $1.92M | ﹤0.01% |
112,036
-153,285
| -58% | -$2.7M |
|
1954
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.13B
| $1.92M | ﹤0.01% |
17,474
+263
| +2% | +$30.3K |
|
1955
CALL
Axsome Therapeutics
AXSM
$11.7B
| $1.91M | ﹤0.01% |
+27,400
| New | +$2.05M |
|
|
1956
PUT
Axsome Therapeutics
AXSM
$11.7B
| $1.91M | ﹤0.01% |
+27,400
| New | +$2.05M |
|
1957
CALL
State Street SPDR S&P Homebuilders ETF
XHB
$1.61B
| $1.91M | ﹤0.01% |
25,000
-315,000
| -93% | -$25.6M |
|
1958
Ardelyx
ARDX
$1.24B
| $1.91M | ﹤0.01% |
469,133
-176,048
| -27% | -$687K |
|
1959
Amphastar Pharmaceuticals
AMPH
$907M
| $1.91M | ﹤0.01% |
41,590
+3,841
| +10% | +$210K |
|
1960
First Interstate BancSystem
FIBK
$3.67B
| $1.91M | ﹤0.01% |
76,629
-48,875
| -39% | -$1.28M |
|
1961
PUT
Rio Tinto
RIO
$152B
| $1.91M | ﹤0.01% |
30,000
-1,900
| -6% | -$121K |
|
1962
Celldex Therapeutics
CLDX
$2.94B
| $1.91M | ﹤0.01% |
69,355
-1,479
| -2% | -$46.4K |
|
1963
Mueller Industries
MLI
$14.5B
| $1.91M | ﹤0.01% |
101,420
-103,452
| -50% | -$2.05M |
|
1964
Badger Meter
BMI
$3.87B
| $1.9M | ﹤0.01% |
13,230
-13,585
| -51% | -$2.15M |
|
1965
Abeona Therapeutics
ABEO
$355M
| $1.89M | ﹤0.01% |
450,000
+250,000
| +125% | +$946K |
|
1966
iShares US Medical Devices ETF
IHI
$3.17B
| $1.89M | ﹤0.01% |
39,058
+20,081
| +106% | +$1.07M |
|
|
BCPC
1967
Balchem Corp
BCPC
$5.26B
| $1.89M | ﹤0.01% |
15,219
-13,865
| -48% | -$1.84M |
|
1968
Arcosa
ACA
$7.11B
| $1.89M | ﹤0.01% |
26,251
-21,078
| -45% | -$1.6M |
|
1969
WD-40
WDFC
$2.98B
| $1.89M | ﹤0.01% |
9,279
-2,620
| -22% | -$560K |
|
1970
CALL
Fortinet
FTNT
$112B
| $1.88M | ﹤0.01% |
+32,000
| New | +$2.12M |
|
|
NUVL
1971
DELISTED
Nuvalent
NUVL
| $1.88M | ﹤0.01% |
40,842
+9,848
| +32% | +$437K |
|
1972
Lloyds Banking Group
LYG
$85.2B
| $1.87M | ﹤0.01% |
880,061
-193,026
| -18% | -$419K |
|
1973
PUT
Yum! Brands
YUM
$41.9B
| $1.87M | ﹤0.01% |
15,000
| – | – |
|
1974
FIVE9
FIVN
$2.08B
| $1.87M | ﹤0.01% |
29,128
+8,984
| +45% | +$672K |
|
1975
CALL
Etsy
ETSY
$8.12B
| $1.87M | ﹤0.01% |
29,000
+20,000
| +222% | +$1.58M |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.